English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduSalk Institute findings will help inform the development of new and improved treatments for HIV
Tag: AIDS/HIV
How HIV develops resistance to key drugs discovered
The mechanism behind how HIV can develop resistance to a widely-prescribed group of drugs has been uncovered by new research from the Crick and Dana-Farber Cancer Institute, with the findings opening the door to the development of more effective treatments.…
HIV outcomes improved by state-purchased insurance plans, study finds
Health insurance purchased by state AIDS Drug Assistance Programs for people living with HIV in states that did not expand Medicaid are improving outcomes and have the potential to save millions in healthcare costs, a new study suggests. The researchers…
Imaging study of key viral structure shows how HIV drugs work at atomic level
Salk Institute findings will help inform the development of new and improved treatments for HIV
In animal models, a ‘shocking’ step toward a potential HIV cure
Reactivation of latent virus in monkeys and mice
NIH-supported scientists reverse HIV and SIV latency in two animal models
Findings represent progress toward an HIV cure
Researchers reverse HIV latency, important scientific step toward cure
For the first time, scientists at UNC-Chapel Hill, Emory University, and Qura Therapeutics — a partnership between UNC and ViiV Healthcare — use a compound to expose latent HIV to attack in 2 animal models with little or no toxicity
In animal models, a ‘shocking’ step toward a potential HIV cure
Reactivation of latent virus in monkeys and mice
In animal models, a ‘shocking’ step toward a potential HIV cure
Reactivation of latent virus in monkeys and mice
NIH-supported scientists reverse HIV and SIV latency in two animal models
Findings represent progress toward an HIV cure
NIH-supported scientists reverse HIV and SIV latency in two animal models
Findings represent progress toward an HIV cure
Researchers reverse HIV latency, important scientific step toward cure
For the first time, scientists at UNC-Chapel Hill, Emory University, and Qura Therapeutics — a partnership between UNC and ViiV Healthcare — use a compound to expose latent HIV to attack in 2 animal models with little or no toxicity
Researchers reverse HIV latency, important scientific step toward cure
For the first time, scientists at UNC-Chapel Hill, Emory University, and Qura Therapeutics — a partnership between UNC and ViiV Healthcare — use a compound to expose latent HIV to attack in 2 animal models with little or no toxicity
Controlled-release opioid may be leading to heart infections in persons who inject drugs
LONDON, ON – A new study from ICES, Lawson Health Research Institute and Western University suggests that injection drug users prescribed controlled-release hydromorphone are three times more likely to develop endocarditis, a serious bacterial heart infection, when compared to those…
Dying people give last gift to help cure HIV
La Jolla, California (January 18, 2020). A new study published in the Journal of Clinical Investigation enrolled people with HIV who also happened to have a terminal illness to study where HIV hides in the human body so doctors can…
Dying people give last gift to help cure HIV
La Jolla, California (January 18, 2020). A new study published in the Journal of Clinical Investigation enrolled people with HIV who also happened to have a terminal illness to study where HIV hides in the human body so doctors can…
Dr. Sallie Permar receives the SPR Award in honor of E. Mead Johnson
HOUSTON, Jan. 15, 2020 – The Society for Pediatric Research (SPR) is pleased to announce Sallie Permar, MD, PhD, as the recipient of the 2020 SPR Award in honor of E. Mead Johnson, the most prestigious honor bestowed by the…
Dr. Sallie Permar receives the SPR Award in honor of E. Mead Johnson
HOUSTON, Jan. 15, 2020 – The Society for Pediatric Research (SPR) is pleased to announce Sallie Permar, MD, PhD, as the recipient of the 2020 SPR Award in honor of E. Mead Johnson, the most prestigious honor bestowed by the…
HIV ‘hotspots’ not necessarily major drivers of new infections
Areas of high HIV prevalence, known as ‘hotspots’, do not necessarily fuel the epidemic in the wider population, say researchers. Hotspots are often targeted for intense HIV control interventions, including treatment and prevention, to maximise their effect and reach the…
New discovery on the activity and function of MAIT cells during acute HIV infection
In a new study published in Nature Communications , researchers at Karolinska Institutet show that MAIT cells (mucosa-associated invariant T cells), part of the human immune system, respond with dynamic activity and reprogramming of gene expression during the initial phase…
New discovery on the activity and function of MAIT cells during acute HIV infection
In a new study published in Nature Communications , researchers at Karolinska Institutet show that MAIT cells (mucosa-associated invariant T cells), part of the human immune system, respond with dynamic activity and reprogramming of gene expression during the initial phase…
Truvada should remain first choice for HIV prevention, experts say
Boston, MA – In October 2019, the U.S. Food and Drug Administration approved a second medication for use as HIV preexposure prophylaxis, also known as PrEP, sparking controversy about which drug should be prescribed. Gilead Sciences, which manufactures both approved…
Truvada should remain first choice for HIV prevention, experts say
Boston, MA – In October 2019, the U.S. Food and Drug Administration approved a second medication for use as HIV preexposure prophylaxis, also known as PrEP, sparking controversy about which drug should be prescribed. Gilead Sciences, which manufactures both approved…
Truvada should remain first choice for HIV prevention, experts say
Boston, MA – In October 2019, the U.S. Food and Drug Administration approved a second medication for use as HIV preexposure prophylaxis, also known as PrEP, sparking controversy about which drug should be prescribed. Gilead Sciences, which manufactures both approved…
Smoking HIV out of dormancy
A newly discovered mechanism allows the immune system to detect and respond to HIV
Smoking HIV out of dormancy
A newly discovered mechanism allows the immune system to detect and respond to HIV
Routine HIV screening in general practice boosts testing and early diagnosis
Offering HIV screening to new patients in general practice on a routine basis increases testing rates and improves detection and earlier diagnosis, research co-led by Queen Mary University of London and UCL suggests. HIV testing rates in general practice are…
Single dose of antibodies can knock out HIV in newborns
Study: Combination of 2 antibodies taken 30 hours after virus exposure prevents infection in baby monkeys
Does timing matter for initiating HIV therapy in infants?
Study shows similar results for starting at 2 days or 2 weeks; ART alone unlikely to lead to remission
Single dose of antibodies can knock out HIV in newborns
Study: Combination of 2 antibodies taken 30 hours after virus exposure prevents infection in baby monkeys
Does timing matter for initiating HIV therapy in infants?
Study shows similar results for starting at 2 days or 2 weeks; ART alone unlikely to lead to remission
Study suggests antiretroviral therapy does not restore disease immunity
Amnesia to the immunity afforded by childhood vaccines and infections prior to HIV infection may present a significant health risk
Study suggests antiretroviral therapy does not restore disease immunity
Amnesia to the immunity afforded by childhood vaccines and infections prior to HIV infection may present a significant health risk
Back new PACK training tackles common diseases in developing countries
An educational outreach training package has shown to be effective for improving management of respiratory diseases in Brazil, raising hopes it could be rolled out to treat other common, severe diseases in low- and middle-income countries. Researchers from the University…
Back new PACK training tackles common diseases in developing countries
An educational outreach training package has shown to be effective for improving management of respiratory diseases in Brazil, raising hopes it could be rolled out to treat other common, severe diseases in low- and middle-income countries. Researchers from the University…
The Lancet Infectious Diseases: Scientists call for government action to control and treat unprecedented outbreak of childhood HIV in Pakistan
First scientific analysis of outbreak finds average age of children affected is 3 years
Even with early treatment, HIV still attacks young brains, says MSU study
EAST LANSING, Mich. – The vast majority of children living with HIV today are in sub-Saharan Africa. While early antiretroviral therapy, or ART, has ensured less deadly outcomes for children living with and exposed to HIV, studies show the virus…
Children with HIV score below HIV-negative peers in cognitive, motor function tests
Disparity worsens over time despite early HIV treatment, NIH study finds
HIV/AIDS, diabetes, organ transplant drugs possible Alzheimer’s treatment approaches
Alzheimer’s Association part the cloud program takes the field a step closer to effective therapy with 5 new grants
Even with early treatment, HIV still attacks young brains, says MSU study
EAST LANSING, Mich. – The vast majority of children living with HIV today are in sub-Saharan Africa. While early antiretroviral therapy, or ART, has ensured less deadly outcomes for children living with and exposed to HIV, studies show the virus…
Children with HIV score below HIV-negative peers in cognitive, motor function tests
Disparity worsens over time despite early HIV treatment, NIH study finds
Researchers support new strategies for HIV control
The search for a cure to AIDS has partly focused on ways to eradicate infected cells. Now, new research from Karolinska Institutet in Sweden and the University of Pennsylvania in the U.S. shows that this approach may not be necessary…
Pregnant women with HIV often not given recommended treatment
BOSTON – Women living with HIV who are also pregnant don’t always receive recommended antiretroviral medications, according to a recent study of prescribing patterns carried out by a MassGeneral Hospital for Children (MGHfC) researcher in collaboration with other members of…
HIV/AIDS, diabetes, organ transplant drugs possible Alzheimer’s treatment approaches
Alzheimer’s Association part the cloud program takes the field a step closer to effective therapy with 5 new grants
Researchers support new strategies for HIV control
The search for a cure to AIDS has partly focused on ways to eradicate infected cells. Now, new research from Karolinska Institutet in Sweden and the University of Pennsylvania in the U.S. shows that this approach may not be necessary…
Pregnant women with HIV often not given recommended treatment
BOSTON – Women living with HIV who are also pregnant don’t always receive recommended antiretroviral medications, according to a recent study of prescribing patterns carried out by a MassGeneral Hospital for Children (MGHfC) researcher in collaboration with other members of…
New metrics needed to evaluate and combat HIV epidemics in the US
A new peer-reviewed commentary published in the January issue of the American Journal of Public Health argues for new metrics to evaluate the public health response to HIV in the United States. The U.S. Department of Health and Human Services…
New metrics needed to evaluate and combat HIV epidemics in the US
A new peer-reviewed commentary published in the January issue of the American Journal of Public Health argues for new metrics to evaluate the public health response to HIV in the United States. The U.S. Department of Health and Human Services…
Taking shape: Scientists propose new structure for shell of HIV-1 virus
A newly proposed model for the shape of the HIV-1 viral shell may change how we understand the disease
Taking shape: Scientists propose new structure for shell of HIV-1 virus
A newly proposed model for the shape of the HIV-1 viral shell may change how we understand the disease